NCT02426892 Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors Status COMPLETED Phase PHASE2
NCT02423343 A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02420938 Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients Status WITHDRAWN Phase PHASE2
NCT02419417 Study of BMS-986158 in Subjects With Select Advanced Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT02415400 A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart Status COMPLETED Phase PHASE4
NCT02413372 A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT02409368 An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC Status COMPLETED Phase PHASE2
NCT02402699 Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan Status COMPLETED Phase N/A
NCT02401854 Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder Status COMPLETED Phase N/A
NCT02393794 Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02389972 Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study Status COMPLETED Phase N/A
NCT02388906 Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma Status COMPLETED Phase PHASE3
NCT02387996 A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer Status COMPLETED Phase PHASE2
NCT02378623 Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli Status WITHDRAWN Phase PHASE2
NCT02375555 Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM Status COMPLETED Phase PHASE2
NCT02374242 Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02369653 A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase Status COMPLETED Phase PHASE3
NCT02368522 Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU) Status COMPLETED Phase N/A